Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.

ABSTRACT:

Aims

Optimal diabetes care requires clear understanding of the incidence of hypoglycaemia in real-world clinical practice. Current data on hypoglycaemia are generally limited to those reported from randomised controlled clinical trials. The Hypoglycaemia Assessment Tool (HAT) study, a non-interventional real-world study of hypoglycaemia, assessed hypoglycaemia in 27 585 individuals across 24 countries. The present study compared the incidence of hypoglycaemia from the HAT study with other similarly designed, large, real-world studies.

Materials and methods

A literature search of PubMed (1995-2017) for population-based studies of insulin-treated patients with type 1 or type 2 diabetes (T1D, T2D), excluding clinical trials and reviews, identified comparable population-based st

SUBMITTER: Pedersen-Bjergaard U 

PROVIDER: S-EPMC6590793 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature